Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 5Thoracic 1Sarcoma 1Other solid neoplasm 1Gynecologic 1Genitourinary 1Classical hematology 1CNS 1

Conditions

Sarcoma 25Central Nervous System Neoplasms 18Astrocytoma 15Gliosarcoma 14Glioblastoma 14Ovarian Neoplasms 12Oligodendroglioma 10Neuroectodermal Tumors, Primitive, Peripheral 10Brain Neoplasms 10Osteosarcoma 9Neuroblastoma 9Testicular Neoplasms 8Glioma 8Dendritic Cell Sarcoma, Interdigitating 8Medulloblastoma 7Breast Neoplasms 7Choroid Plexus Neoplasms 6Carcinosarcoma 6Burkitt Lymphoma 6Wilms Tumor 5Testicular Germ Cell Tumor 5Stomach Neoplasms 5Rhabdoid Tumor 5Optic Nerve Glioma 5Neoplasms 5Lymphoma, Non-Hodgkin 5Lymphoma, Large B-Cell, Diffuse 5Kidney Neoplasms 5Head and Neck Neoplasms 5Retinoblastoma 4

Interventions

Cyclophosphamide 3tislelizumab 1spartalizumab 1pembrolizumab 1montanide ISA 51 1entinostat 1Thrombopoietin 1LY2940680 1Interleukin-2 1Immunologic Techniques 1Imatinib Mesylate 1Ifosfamide 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Etoposide 1Cryosurgery 1Carboplatin 1Blood Specimen Collection 1Bevacizumab 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Uveal Melanoma × Carboplatin × Sarcoma × Clear all
NCT00003597 2014-07-24

Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors

Children's Oncology Group

Phase 1 Completed
16 enrolled
CNSClassical hematologyDermatologicGenitourinaryGynecologicOther solid neoplasmSarcoma

Uveal Melanoma, Astrocytoma, Carcinoma, Renal Cell, Medulloblastoma, Melanoma, Neoplasms, Wilms Tumor, Neuroblastoma, Neutropenia, Retinoblastoma, Osteosarcoma, Testicular Neoplasms, Thrombocytopenia, Neuroectodermal Tumors, Primitive, Peripheral, Optic Nerve Glioma, Gestational Trophoblastic Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡